API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
20
PharmaCompass offers a list of Medroxyprogesterone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Medroxyprogesterone Acetate manufacturer or Medroxyprogesterone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Medroxyprogesterone Acetate manufacturer or Medroxyprogesterone Acetate supplier.
PharmaCompass also assists you with knowing the Medroxyprogesterone Acetate API Price utilized in the formulation of products. Medroxyprogesterone Acetate API Price is not always fixed or binding as the Medroxyprogesterone Acetate Price is obtained through a variety of data sources. The Medroxyprogesterone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 17-Acetate, Medroxyprogesterone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 17-Acetate, Medroxyprogesterone, including repackagers and relabelers. The FDA regulates 17-Acetate, Medroxyprogesterone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 17-Acetate, Medroxyprogesterone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 17-Acetate, Medroxyprogesterone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 17-Acetate, Medroxyprogesterone supplier is an individual or a company that provides 17-Acetate, Medroxyprogesterone active pharmaceutical ingredient (API) or 17-Acetate, Medroxyprogesterone finished formulations upon request. The 17-Acetate, Medroxyprogesterone suppliers may include 17-Acetate, Medroxyprogesterone API manufacturers, exporters, distributors and traders.
click here to find a list of 17-Acetate, Medroxyprogesterone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 17-Acetate, Medroxyprogesterone DMF (Drug Master File) is a document detailing the whole manufacturing process of 17-Acetate, Medroxyprogesterone active pharmaceutical ingredient (API) in detail. Different forms of 17-Acetate, Medroxyprogesterone DMFs exist exist since differing nations have different regulations, such as 17-Acetate, Medroxyprogesterone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 17-Acetate, Medroxyprogesterone DMF submitted to regulatory agencies in the US is known as a USDMF. 17-Acetate, Medroxyprogesterone USDMF includes data on 17-Acetate, Medroxyprogesterone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 17-Acetate, Medroxyprogesterone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 17-Acetate, Medroxyprogesterone suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 17-Acetate, Medroxyprogesterone Drug Master File in Japan (17-Acetate, Medroxyprogesterone JDMF) empowers 17-Acetate, Medroxyprogesterone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 17-Acetate, Medroxyprogesterone JDMF during the approval evaluation for pharmaceutical products. At the time of 17-Acetate, Medroxyprogesterone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 17-Acetate, Medroxyprogesterone suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 17-Acetate, Medroxyprogesterone Drug Master File in Korea (17-Acetate, Medroxyprogesterone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 17-Acetate, Medroxyprogesterone. The MFDS reviews the 17-Acetate, Medroxyprogesterone KDMF as part of the drug registration process and uses the information provided in the 17-Acetate, Medroxyprogesterone KDMF to evaluate the safety and efficacy of the drug.
After submitting a 17-Acetate, Medroxyprogesterone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 17-Acetate, Medroxyprogesterone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 17-Acetate, Medroxyprogesterone suppliers with KDMF on PharmaCompass.
A 17-Acetate, Medroxyprogesterone CEP of the European Pharmacopoeia monograph is often referred to as a 17-Acetate, Medroxyprogesterone Certificate of Suitability (COS). The purpose of a 17-Acetate, Medroxyprogesterone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 17-Acetate, Medroxyprogesterone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 17-Acetate, Medroxyprogesterone to their clients by showing that a 17-Acetate, Medroxyprogesterone CEP has been issued for it. The manufacturer submits a 17-Acetate, Medroxyprogesterone CEP (COS) as part of the market authorization procedure, and it takes on the role of a 17-Acetate, Medroxyprogesterone CEP holder for the record. Additionally, the data presented in the 17-Acetate, Medroxyprogesterone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 17-Acetate, Medroxyprogesterone DMF.
A 17-Acetate, Medroxyprogesterone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 17-Acetate, Medroxyprogesterone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 17-Acetate, Medroxyprogesterone suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 17-Acetate, Medroxyprogesterone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 17-Acetate, Medroxyprogesterone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 17-Acetate, Medroxyprogesterone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 17-Acetate, Medroxyprogesterone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 17-Acetate, Medroxyprogesterone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 17-Acetate, Medroxyprogesterone suppliers with NDC on PharmaCompass.
17-Acetate, Medroxyprogesterone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 17-Acetate, Medroxyprogesterone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 17-Acetate, Medroxyprogesterone GMP manufacturer or 17-Acetate, Medroxyprogesterone GMP API supplier for your needs.
A 17-Acetate, Medroxyprogesterone CoA (Certificate of Analysis) is a formal document that attests to 17-Acetate, Medroxyprogesterone's compliance with 17-Acetate, Medroxyprogesterone specifications and serves as a tool for batch-level quality control.
17-Acetate, Medroxyprogesterone CoA mostly includes findings from lab analyses of a specific batch. For each 17-Acetate, Medroxyprogesterone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
17-Acetate, Medroxyprogesterone may be tested according to a variety of international standards, such as European Pharmacopoeia (17-Acetate, Medroxyprogesterone EP), 17-Acetate, Medroxyprogesterone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (17-Acetate, Medroxyprogesterone USP).